Hib

BIOLOGICAL4 trials

Sponsors

Novartis Vaccines, Duke University, Pfizer

Conditions

ApneaApnea NeonatalMeningitis, MeningococcalMeningococcal DiseasePneumococcal Conjugate VaccinePneumococcal InfectionsPrematurity

Phase 2

B Cell Response to a Primary and a Booster Course of the Novartis Meningococcal ACWY Conjugate Vaccine in Healthy Infants

CompletedNCT00488683

Novartis VaccinesMeningococcal Disease

Start: 2007-07-31End: 2009-06-30Updated: 2014-10-01

Phase 3

A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants

CompletedNCT00474526

Novartis VaccinesMeningitis, Meningococcal

Start: 2007-03-31End: 2009-11-30Updated: 2014-03-24

A Study Assessing 13-valent Pneumococcal Conjugate Vaccine in Healthy Chinese Infants and Young Children

CompletedNCT03574389

PfizerPneumococcal Conjugate Vaccine, Pneumococcal Infections

Start: 2018-06-23End: 2023-10-13Updated: 2024-11-05

Phase 4

Apnea in Hospitalized Preterm Infants Following the Administration of Routine Childhood Vaccines

CompletedNCT03530124

Duke UniversityApnea, Apnea Neonatal, Prematurity

Start: 2018-07-17End: 2021-11-01Updated: 2024-02-14

Related Papers

Apnea After 2-Month Vaccinations in Hospitalized Preterm Infants

JAMA Pediatrics2025-01-063 citations

A randomized, open-label, phase 3 study evaluating safety and immunogenicity of 13-valent pneumococcal conjugate vaccine in Chinese infants and children under 6 years of age

Human Vaccines & Immunotherapeutics2023-08-013 citations